- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05415059
LEAFix Adhesion in Healthy Volunteers
August 5, 2022 updated by: Liverpool University Hospitals NHS Foundation Trust
Laryngeal, Endotracheal Airway Fixator (LEAFix): In Vivo Skin Adhesion Verification Protocol
This study compares the adhesiveness of the 3M material to be used in the final design.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The material is taken from a CE marked stoma bag. Strips will be placed on to healthy volunteers on the arm and face for 10 minutes and 24 hours. A force gauge will measure the peel force. This will be compared to previous testing on metal.
Participants will also be assessed and followed up for any adverse skin issues.
Study Type
Interventional
Enrollment (Anticipated)
32
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 61 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy volunteers
- Not been in a trial in last 12 weeks
- mild to no skin issues
Exclusion Criteria:
- any significant allergies
- any allergies to skin adhesive
- any medium to severe skin issues
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Main Cohort
Cohort of healthy volunteers to have device affixed
|
Strips of Covatech Stoma bag used to asses adhesion of 3M material to be used in LEAFix device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adhesion after 24 hours
Time Frame: 24 hours
|
Adhesion after 24 hours of placement inferred from peel force measured with a force gauge at 10 minutes and 24 hours measured in Newtons (N)
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin outcomes
Time Frame: 7 days
|
Asses for any issues with adhesion to the skin with a questionnaire on day 7 - likehart scale for different skin parameters ie.
degree of itchiness with 0 being none and 3 being severe
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 10, 2022
Primary Completion (Anticipated)
October 1, 2022
Study Completion (Anticipated)
November 1, 2022
Study Registration Dates
First Submitted
June 1, 2022
First Submitted That Met QC Criteria
June 8, 2022
First Posted (Actual)
June 10, 2022
Study Record Updates
Last Update Posted (Actual)
August 8, 2022
Last Update Submitted That Met QC Criteria
August 5, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SP0935
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
For internal use
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adhesion
-
Amsterdam UMC, location VUmcCompletedAdhesions Pelvic | Adhesion; Uterus | Adhesion; BladderNetherlands
-
Radboud University Medical CenterOnze Lieve Vrouwe GasthuisTerminatedPostoperative Adhesion | Peritoneal Adhesion, NosNetherlands
-
Hua DuanRecruitingIntrauterine Adhesion | Database for Intrauterine Adhesion | Risk Factors for Intrauterine Adhesion | Risk Stratification and Prognostic AssessmentChina
-
Rocket Pharmaceuticals Inc.California Institute for Regenerative Medicine (CIRM)CompletedLeukocyte Adhesion Defect - Type ISpain, United States, United Kingdom
-
Rocket Pharmaceuticals Inc.WithdrawnLeukocyte Adhesion Defect - Type ISpain
-
Limin FengRecruitingIntrauterine AdhesionChina
-
Fu Xing Hospital, Capital Medical UniversityRecruitingIntrauterine AdhesionChina
-
Second Affiliated Hospital, School of Medicine,...Shanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaRecruitingIntrauterine AdhesionChina
-
WomedCompletedIntrauterine AdhesionBelgium, France, Netherlands
-
Qi ZhouTongji HospitalUnknown
Clinical Trials on Covatech Stoma bag material
-
Acibadem UniversityCompletedPatient Satisfaction | Patient Relations, NurseTurkey